Using evidence-based medicine to deliver cost-effective care in CHD Carlene Todd Newsletter Article 11 February 2013 Pages: 3 - 5
Meta-analysis remains useful in cost-effectiveness analysis Newsletter Article 11 February 2013 Pages: 6 - 6
Polypharmacy a major, potentially preventable, health problem Newsletter Article 11 February 2013 Pages: 7 - 7
Warfarin costs not higher than aspirin post-MI in Italy Newsletter Article 11 February 2013 Pages: 7 - 7
Community pharmacists helpful in formulary development Newsletter Article 11 February 2013 Pages: 8 - 8
Abciximab not cost saving in unstable angina pectoris Newsletter Article 11 February 2013 Pages: 8 - 8
PCA more costly for pain control than regular IM therapy Newsletter Article 11 February 2013 Pages: 9 - 9
US quality-of-care improvements save lives, cut costs Newsletter Article 11 February 2013 Pages: 9 - 9
QOL in chronic hepatitis C improved with interferon Newsletter Article 11 February 2013 Pages: 11 - 11